The associations of gender, sexual identity and competing needs with healthcare utilization among people with HIV/AIDS

Journal of the National Medical Association

Volumn 99, Issue 4, 2007, Pages 419-427

  Penniman, Typhanye V ^a,c   Taylor, Stephanie L ^b   Bird, Chloe E ^b   Beckman, Robin ^b   Collins, Rebecca L ^b   Cunningham, William ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b RAND CORPORATION   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Gender; Health service utilization; HIV AIDS; Sexual identity

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AMBULATORY CARE; ARTICLE; BISEXUAL MALE; CONSULTATION; ECONOMIC ASPECT; EMERGENCY WARD; FEMALE; GENDER; GENDER IDENTITY; HEALTH CARE NEED; HEALTH CARE UTILIZATION; HETEROSEXUAL MALE; HIGH RISK POPULATION; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCOME; MAJOR CLINICAL STUDY; MALE; MALE HOMOSEXUAL; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEX DIFFERENCE; SOCIAL ASPECT; SOCIAL NETWORK;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AMBULATORY CARE; FEMALE; GENDER IDENTITY; HEALTH SERVICES NEEDS AND DEMAND; HETEROSEXUALITY; HIV INFECTIONS; HOMOSEXUALITY, MALE; HOSPITALIZATION; HOSPITALS; HUMANS; MALE; MIDDLE AGED; NEEDS ASSESSMENT; PILOT PROJECTS; RISK FACTORS; SEX FACTORS; SEXUALITY; UNITED STATES; WOMEN'S HEALTH;

EID: 34247182661     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Kenagy GP, Linsk NL, Bruce D, et al. Service utilization, service barriers, and gender among HIV-positive consumers in primary care. AIDS Patient Care STDS. 2003;17:235-244.
2. Davidson AJ, Bertram SL, Lezotte DC, et al. Comparison of Health Status, Socioeconomic Characteristics, and Knowledge and Use of HIV-related Resources Between HIV-infected Women and Men. Med Care. 1998; 36(12):1676-1684.
3. Mor V, Fleishman JA, Dresser M, et al. Variation in health service use among HIV-infected patients. Med Care. 1992:30(1):17-29.
4. Solomon L, Frank R, Vlahov D, et al. Utilization of health services in a cohort of intravenous drug users with known HIV-1 Serostatus. Am J Public Health. 1991;81(10):1285-1290.
5. Crystal S. Health-care barriers and utilization patterns among intravenous-drug users with HIV disease. AIDS Public Policy J. 1992;7(3):187-198.
6. Graham NM, Jacobson LP, Kuo V, et al. Access to Therapy in the Multicenter AIDS Cohort Study, 1989-1992. J Clin Epidemiol. 1994;47(9):1003-1012.
7. Andersen RM, Bozzette SA, Shapiro MF, et al. Access of Vulnerable Groups to Antiretroviral Therapy Among Persons in Care for HIV Disease in the U.S. Health Serv Res. 2000:35(2):389-416.
8. Gebo KA, Fleishman JA, Conviser R, et al. Racial and gender disparities in receipt of highly active antiretroviral therapy persist in a multistate sample of HIV patients in 2001. J Acquir Immune Defic Syndr. 2005;38:96-103.
9. Giordano TP, White AC Jr, Saja P, et al. Factors associated with the use of highly active antiretroviral therapy in patients newly entering care in an urban clinic. J Acquir Immune Defic Syndr. 2003;32:399-405.
10. Mocroft A, Gill MJ, Davidson W, et al. Are there gender differences in starting protease inhibitors, HAART, and disease progression despite equal access to care? J Acquir Immune Defic Syndr. 2000;24:475-482.
11. Turner BJ, Markson L, Cocroft J, et al. Clinic HIV-focused features and prevention of Pneumocystis carinii pneumonia. J Gen Intern Med. 1998; 13:16-23.
12. Schwarcz SK, Katz MH, Hirozawa A, et al. Prevention of Pneumocystis carinii pneumonia: Who are we missing? AIDS. 1997;11:1263-1268.
13. Celentano DD, Vlahov D, Cohn SE, et al. Self-Reported Antiretroviral Therapy in Injection Drug Users. JAMA. 1998;280(6):544-546.
14. Cunningham WE, Andersen RM, Katz MH, et al. The Impact of Competing Needs for Basic Subsistence on Access to Medical Care for Persons with HIV Receiving Care in the United States. Med Care. 1999;37(12):1270-1281.
15. Sowell RL, Moneyham L, Aranda-Naranjo B. The care of women with AIDS: special needs and considerations. Nurs Clin North Am. 1999;34:179-199.
16. Lehrman S, Gimbel R, Freedman J, et al. Development and implementation of an HIV/AIDS case management outcomes assessment programme. AIDS Care. 2002;14:751-761.
17. Box TL, Olsen M, Oddone EZ, et al. Healthcare access and utilization by patients infected with human immunodeficiency virus: does gender matter? J Womens Health (Larchmt). 2003;12:391-397.
18. Stein MD, Crystal S, Cunningham WE, et al. Delays in Seeking HIV Care due to Competing Caregiver Responsibilities. Am J Public Health. 2000; 90(7):1138-1140.
19. Asch SM, Gifford AL, Bozzette SA, et al. Underuse of primary Mycobacterium avium complex and Pneumocystis carinii prophylaxis in the United States. J Acquir Immune Defic Syndr. 2001;28:340-344.
20. Shapiro MF, Morton SC, McCaffrey DF, et al. Variations in the care of HIV-infected adults in the United States: results from the HIV Cost and Services Utilization Study. JAMA. 1999;281:2305-2315.
21. Eisenman DP, Cunningham WE, Zierler S, et al. Effect of Violence on Utilization of Services and Access to Care in Persons with HIV. J Gen Intern Med. 2003;18:125-127.
22. Ciccarone DH, Kanouse DE, Collins RL, et al. Sex without disclosure of positive HIV serostatus in a US probability sample of persons receiving medical care for HIV infection. Am J Public Health. 2003;93(6):949-954.
23. Bombardier C. Outcome assessments in the evaluation of treatment of spinal disorders: summary and general recommendations. Spine. 2000;25: 3100-103.
24. Beaton DE, Schemitsch E. Measures of health-related quality of life and physical function. Clin Orthop. 2003;90-105.
25. Keruly JC, Conviser R, Moore RD. Association of medical insurance and other factors with receipt of antiretroviral therapy. Am J Public Health. 2002;92:852-857.
26. Moore RD, Stanton D, Gopalan R, et al. Racial differences in the use of drug therapy for HIV disease in an urban community. N Engl J Med. 1994; 330(11):763-768.
27. Galvan FH, Collins R, Kanouse DE, et al. Abuse in the close relationships of people with HIV. AIDS Behav. 2004;8:441-451.
28. Bogart LM, Collins RL, Cunningham WE, et al. The Association of Partner Abuse with Risky Sexual Behaviors Among Women and Men with HIV/AIDS. AIDS Behav. 2005;9(3):323-333.
29. Collins RL. Social support provision to HIV-infected gay men. J Appl Soc Psychol. 1994;24(20):1848-1869.
30. Katz MH, Bindman AB, Keane D, et al. CD4 Lymphocyte counts as indicator of delay in seeking human immunodeficiency virus-related treatment. Arch Intern Med. 1992;152:1501-1504.
31. Stein MD, Piette J, Mor V, et al. Differences in access to zidovudine (AZT) among symptomatic HIV-infected persons. J Gen Intern Med. 1991;6:35-40.
32. Bogart LM, Collins RL, Kanouse D, et al. Patterns and Correlates of Deliberate Abstinence Among Men and Women with HIV/AIDS. Am J Public Health. 2006;96(6):1078-1084.
33. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report, 2004. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. 2006;16:1-46.
34. Carrieri MP, Moatti JP, Vlahov D, et al. Access to antiretroviral treatment among French HIV infected injection drug users: the influence of continued drug use. MANIF 2000 Study Group. J Epidemiol Community Health. 1999;53:4-8.
35. Frankel MR, Shapiro MF, Duan N, et al. National Probability Samples in Studies of Low-Prevalence Diseases, part 2: Designing and Implementing the HIV Cost and Services Utilization Study Sample. Health Serv Res. 1999; 34(5):969-992.
36. Brick JM, Kalton G. Handling Missing Data in Survey Research. Stat Methods Med Res. 1996;5:215-238.
37. Collins RL. Social identity and HIV infection: the experiences of gay men living with HIV. Delerga VJ, Barbee AP, eds. HIV and Social Interaction. Thousand Oaks, CA:Sage Publications; 1998:30-55.
38. Dobalian A, Tsao JC, Duncan RP. Pain and the Use of Outpatient Services Among Persons With HIV: Results From a Nationally Representative Survey. Med Care. 2004;42:129-138.
39. Cunningham WE, Crystal S, Bozzette S, et al. The association of health-related quality of life with survival among persons with HIV infection in the United States. J Gen Intern Med. 2005;20:21-27.
40. Zingmond DS, Kilbourne AM, Justice AC, et al. Differences in Symptom Expression in Older HIV-Positive Patients: The Veterans Aging Cohort 3 Site Study and HIV Cost and Service Utilization Study Experience. J Acquir Immune Defic Syndr. 2003;33(2):S84-S92.
41. Mirowsky J, Ross CE. Control of defense? Depression and the sense of control over good and bad outcomes. J Health Soc Behav. 1990; 31(March):71-86.
42. Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pen Soc Psychol. 1986;51(6):1173-1182.
43. Thompson AS, Blankenship KM, Selwyn PA, et al. Evaluation of an innovative program to address the healtlvand social service needs of drug-using women with or at risk for HIV infection. J Community Health. 1998; 23:419-440.
44. Gebo KA, Diener-West M, Moore RD. Hospitalization rates in an urban cohort after the introduction of highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2001;27(2):143-152.
45. Floris-Moore M, Lo Y, Klein RS, et al. Gender and hospitalization patterns among HIV-infected drug users before and after the availability of highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2003;34:331-337.
46. Centers for Disease Control and Prevention and the United States Department of Health and Human Services. Health, United States, 2003: Chartbook and Trends in the Health of Americans; 2003.
47. Centers for Disease Control and Prevention. National Hospital Ambulatory Medical Care Survey; 2002.
48. Verbrugge LM. Gender and Health: an Update on Hypotheses and Evidence. J Health Soc Behav. 1985;26:156-182.